Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview.

MLA

de Castro, Karine Cappuccio, et al. “Pluronic® Triblock Copolymer-Based Nanoformulations for Cancer Therapy: A 10-Year Overview.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 353, Jan. 2023, pp. 802–22. EBSCOhost, https://doi.org/10.1016/j.jconrel.2022.12.017.

APA

de Castro, K. C., Coco, J. C., Dos Santos, É. M., Ataide, J. A., Martinez, R. M., do Nascimento, M. H. M., Prata, J., da Fonte, P. R. M. L., Severino, P., Mazzola, P. G., Baby, A. R., Souto, E. B., de Araujo, D. R., & Lopes, A. M. (2023). Pluronic® triblock copolymer-based nanoformulations for cancer therapy: A 10-year overview. Journal of Controlled Release : Official Journal of the Controlled Release Society, 353, 802–822. https://doi.org/10.1016/j.jconrel.2022.12.017

Chicago

de Castro, Karine Cappuccio, Julia Cedran Coco, Érica Mendes Dos Santos, Janaína Artem Ataide, Renata Miliani Martinez, Mônica Helena Monteiro do Nascimento, João Prata, et al. 2023. “Pluronic® Triblock Copolymer-Based Nanoformulations for Cancer Therapy: A 10-Year Overview.” Journal of Controlled Release : Official Journal of the Controlled Release Society 353 (January): 802–22. doi:10.1016/j.jconrel.2022.12.017.